Der sås en forbedring på 20% hos 48% af patienterne, som fik rotigotin og hos 19% af patienterne, som fik placebo (forskel 29% CI95% 18%; 39%, p < 0, 0001).
An improvement of 20% was seen in 48% of the subjects receiving rotigotine and in 19% of the subjects receiving placebo (Difference 29% CI95% 18%; 39%, p < 0.0001).